Wu Xinhui, Fang Xiaoxin, Lu Feng, Chen Qiong, Liu Junjian, Zheng Longpo
Department of Orthopedics, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
Department of Endocrinology and Metabolism, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China.
EFORT Open Rev. 2024 Aug 1;9(8):712-722. doi: 10.1530/EOR-23-0148.
Ferroptosis is a novel form of programmed cell death, distinguished from apoptosis, autophagy, and programmed necrosis and has received much attention since it was defined in 2012. Ferroptotic cells physiologically exhibit iron metabolism dysregulation, oxidative stress, and lipid peroxidation. Morphologically, they show plasma membrane disruption, cytoplasmic swelling, and mitochondrial condensation. Osteoporosis is taken more and more seriously as the proportion of the aging population continues to increase globally. Interestingly, ferroptosis has been demonstrated to be involved in the development and progression of osteoporosis in many extant studies. The review summarizes iron metabolism, lipid peroxidation, and the different regulatory signals in ferroptosis. Changes in signaling mechanisms within osteoblasts, osteoclasts, and osteocytes after ferroptosis occur are explained here. Studies showed ferroptosis play an important role in different osteoporosis models (diabetes osteoporosis, postmenopausal osteoporosis, glucocorticoid-induced osteoporosis). Inhibitors and EC (Exos) targeting ferroptosis could ameliorate bone loss in osteoporotic mice by protecting cells against lipid peroxidation. Shortly, we hope that more effective and appropriate clinical therapy means will be utilized in the treatment of osteoporosis.
铁死亡是一种新型的程序性细胞死亡形式,有别于凋亡、自噬和程序性坏死,自2012年被定义以来备受关注。铁死亡细胞在生理上表现出铁代谢失调、氧化应激和脂质过氧化。在形态学上,它们表现为质膜破裂、细胞质肿胀和线粒体凝聚。随着全球老龄化人口比例持续上升,骨质疏松症越来越受到重视。有趣的是,在许多现有研究中,铁死亡已被证明与骨质疏松症的发生和发展有关。本文综述了铁代谢、脂质过氧化以及铁死亡中不同的调控信号。本文解释了铁死亡发生后成骨细胞、破骨细胞和骨细胞内信号机制的变化。研究表明,铁死亡在不同的骨质疏松模型(糖尿病性骨质疏松、绝经后骨质疏松、糖皮质激素诱导的骨质疏松)中起重要作用。靶向铁死亡的抑制剂和外泌体(Exos)可通过保护细胞免受脂质过氧化作用来改善骨质疏松小鼠的骨质流失。简而言之,我们希望在骨质疏松症的治疗中采用更有效、更合适的临床治疗手段。